E88.3
ICD-10BillableTumor lysis syndrome
Official ICD-10-CM descriptor (FY2026)
Tumor lysis syndrome
E88.3 is valid for submission on a claim — CMS flags it as a billable, specific code.
Inclusion terms
- Tumor lysis syndrome (spontaneous)
- Tumor lysis syndrome following antineoplastic drug chemotherapy
Use additional code
Report an additional code to identify the associated condition.
- code for adverse effect, if applicable, to identify drug (T45.1X5)
Related codes in E88
- E88.0Disorders of plasma-protein metabolism, NECcategory
- E88.1Lipodystrophy, not elsewhere classifiedcategory
- E88.2Lipomatosis, not elsewhere classified
- E88.4Mitochondrial metabolism disorderscategory
- E88.8Other specified metabolic disorderscategory
- E88.9Metabolic disorder, unspecified
- E88.AWasting disease (syndrome) due to underlying condition
Where this code sits
- Parent code
- E88
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
ICD-10-CM FY2026. Centers for Medicare & Medicaid Services (CMS) / National Center for Health Statistics (NCHS), “2026 ICD-10-CM Code Descriptions in Tabular Order” (icd10cm_order_2026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.